|
E-Newsletter • September 2026 |
▼ ADVERTISEMENT
Editor's E-Note
September is a time for reflection and awareness. As we recognize National Suicide Prevention Month, we are reminded of the importance of supporting individuals and families affected by mental health challenges. This month also marks the 25th anniversary of the September 11 attacks, offering an opportunity to remember those lost and reflect on the lasting impact of trauma.
In that spirit, this month's exclusive examines new research into PTSD and why women are more likely to develop the condition than men. By exploring differences in how fear memories are formed, researchers hope to advance our understanding of trauma and contribute to more effective treatment approaches in the future.
We welcome your comments at SWTeditor@gvpub.com. Visit our website at www.SocialWorkToday.com, like our Facebook page, and follow us on X, formerly known as Twitter.
— Heather Hogstrom, editor |
|
|
|
|
▼ ADVERTISEMENT
Fear Memories Form Differently in Male and Female Brains, Study Finds
The discovery could help explain why women are more likely to develop PTSD and may shape future treatments.
Women are twice as likely as men to develop PTSD—and new research may offer a biological clue as to why.
A Virginia Tech study found that the female brain forms fear memories using a molecular process not seen in the male brain.
The findings suggest that treatments for PTSD may need to be tailored differently for men and women, says the study’s lead researcher, Timothy Jarome, PhD, an associate professor of neurobiology in the School of Animal Sciences located within the College of Agriculture and Life Sciences.
“Women are more likely to have PTSD than men, but they don’t report experiencing more traumatic events,” Jarome says. “This points to a neurobiological mechanism that’s engaged in females during a traumatic event, and it may help explain the difference we see in PTSD.”
|
▼ ADVERTISEMENT
HHS Awards More Than $380 Million to Strengthen America’s Behavioral Health System on 988 Day
On 988 Day, a national initiative observed on September 8 to raise awareness about the 988 Suicide & Crisis Lifeline, the US Department of Health and Human Services and the Substance Abuse and Mental Health Services Administration announced funding to support behavioral health treatment, suicide prevention, and mobile crisis services.
In His Own Words: Inside the Pentagon on 9/11
Antwan C. Williams, assistant dean for communications, marketing, recruitment, and graduate admissions for The University of Texas at Arlington’s School of Social Work and a retired US Army lieutenant colonel, reflects on his experience at the Pentagon on 9/11, the impact of social workers after the attacks, and giving back. |
Amae Health and Google Health Enterprise Collaborate to Integrate Wearable Data Into Mental Health Care
Amae Health, a behavioral health provider focused on serious mental illness, is collaborating with Google Health Enterprise to integrate wearable-derived data into its precision psychiatry care model. Without reliable, scalable biomarkers to objectively measure disease state and progression, it’s difficult for clinicians to detect early warning signs of clinical decline before a patient deteriorates. This collaboration captures critical data via wearable devices like sleep patterns, physical activity, heart rate variability, and changes in daily routines, and delivers it to care teams, allowing clinicians to see how patients are functioning between visits. Combining these behavioral signals with existing clinical data could help clinicians identify changes earlier and predict relapses.
Silo Pharma Receives Patent for Novel PTSD Treatment
Silo Pharma, a developmental-stage biopharmaceutical company, has been granted a patent by the European Patent Office and has been issued a Notice of Allowance by the Canadian Intellectual Property Office for a patent application covering its lead asset, SPC-15, an intranasal 5-HT4 receptor agonist targeting PTSD and other stress-induced psychiatric disorders. The patent, titled “Prophylactic Efficacy of Serotonin 4 Receptor Agonists Against Stress,” covers methods of preventing or delaying stress-induced fear and depressive-like behavior and methods for inducing and/or enhancing stress resilience by administering selected serotonin 4 (5-HT4) receptor agonists prior to a stressor. Silo Pharma intends to utilize the FDA’s streamlined 505(b)(2) regulatory pathway for SPC-15, which could shorten clinical timelines and reduce development costs. |
The nation's top employers and recruiters of social workers advertise in Social Work Today magazine and post their job openings on AHCJobBoard.com. Check out the most recent opportunities that have been submitted by employers across the country!
Featured Employer
Defense Health Agency
Social Worker
Irwin Army Community Hospital, Fort Riley, Kansas, United States
Social Worker (Mental Health Consultant)
Malmstrom Air Force Base, Great Falls, Montana, United States
Social Worker (Clinical)
Reynolds Army Health Clinic, Fort Sill, Oklahoma, United States
Social Worker GS-0185-12
Walter Reed National Military Medical Center, Bethesda, Maryland, United States
Social Worker (Clinical) GS-0185-12
Womack Army Medical Center, Fort Liberty, North Carolina, United States |
|
|
COVER STORY
What Does Addiction Look Like Over 60?
Since many of the side effects of substance use disorder can mimic aging, substance use in older adults often goes unnoticed, but there are warning signs for which social workers can watch.
FEATURE
EMDR Online
An increase in telehealth services has opened up the option for clients who are the right fit to receive eye movement desensitization and reprocessing therapy virtually.
|
|
|
| Advertising Opportunities |
Have a product or service you want to market to social work professionals? Utilize the reach of Social Work Today Magazine to accomplish your marketing goals. Email our experienced account executives today at sales@gvpub.com or call 800-278-4400 for more information.
|
| © 2026 Social Work Today Magazine |
|
|
